{
    "clinical_study": {
        "@rank": "132849", 
        "acronym": "RHEIA-VAC", 
        "arm_group": [
            {
                "arm_group_label": "HPV therapeutic vaccine", 
                "arm_group_type": "Experimental", 
                "description": "ProCervix consists of two recombinant adenylate cyclase (CyaA) proteins, CyaA-HPV 16E7 (C16-1) and CyaA-HPV 18E7 (C18-1) in a 50/50 ratio (C16C18-2 Ag mixture). ProCervix is adjuvanted by Aldara\u2122, a cream containing 5% of imiquimod"
            }, 
            {
                "arm_group_label": "Placebo matching ProCervix", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo matching ProCervix and adjuvanted by Aldara\u2122, a cream containing 5% of imiquimod"
            }
        ], 
        "brief_summary": {
            "textblock": "Human Papillomavirus (HPV) 16 and HPV 18 (the two virus genotypes targeted by the ProCervix\n      vaccine) are the most common HPV genotypes associated with at least 70% of squamous cell\n      carcinomas and 82% of adenocarcinomas of the cervix The strategy of therapeutic vaccination\n      with ProCervix is to activate and enhance the patient's cellular immune response to HPV .\n      The therapeutic vaccine will be used for women infected by HPV 16, HPV 18, or both. The\n      vaccine targets these HPV infected women with normal or mild cervical cellular dyskaryosis\n      as detectable infections with oncogenic potential.\n\n      This will be a double-blind, randomised, placebo-controlled, parallel group study assessing\n      the efficacy of ProCervix or placebo (concomitantly administered with imiquimod cream).\n\n      ProCervix will be delivered with a topical agent, imiquimod, applied to the injection sites\n      as a vaccine adjuvant.\n\n      The population proposed for this study represents an otherwise healthy female population who\n      are infected with HPV 16 and/or HPV 18. The safety and tolerability of this therapeutic\n      vaccine has been shown in the ongoing Phase I study, and the proposed population may in\n      theory derive benefit from this vaccine."
        }, 
        "brief_title": "Phase II Study of HPV Therapeutic Vaccine in HPV Infected Women With Normal Cytology or ASCUS/LSIL", 
        "completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Genital Infection Viral", 
            "HUMAN PAPILLOMA VIRUS"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Papilloma", 
                "Virus Diseases"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  A subject will be eligible for inclusion in this study if the following criteria\n             apply:\n\n               1. Subject is female between the ages of 25 and 50 years (inclusive).\n\n               2. Subject is pre-menopausal .\n\n               3. Subject must have cervical HPV 16 and/or 18 infection confirmed by RT-PCR\n\n               4. Subject has a cervical cytological evaluation with a normal, ASCUS or LSIL\n                  result at baseline.\n\n               5. Subject has employed highly effective contraception the month prior to the first\n                  vaccination and will agree to employ highly effective contraception for at least\n                  12 months after the first vaccination. .\n\n               6. Subject is in general good health based on medical history and physical\n                  examination.\n\n               7. Subject is able to communicate effectively with study personnel and is\n                  considered reliable, willing, and cooperative in terms of compliance with the\n                  protocol requirements.\n\n               8. Subject voluntarily gives written informed consent to participate in the study.\n\n        Exclusion Criteria:\n\n          1. Subject has a current acute or chronic disease, other than infection with HPV, which\n             would be expected to interfere with the planned evaluations of response\n\n          2. Subject has vaginal atrophy with or without topical hormonal therapies or systemic\n             selective estrogen receptor modulators (SERMs).\n\n          3. Subject has prior exposure to HPV prophylactic vaccine or subject has participated in\n             the past in another vaccination clinical trial related to infection with HPV\n\n          4. Current high grade lesions or history of untreated high grade cervical lesion (either\n             CIN2 or CIN3).\n\n          5. Subject has current or a history of cancer of the cervix.\n\n          6. Subject has clinically significant (CS) gynaecological abnormalities that could\n             interfere with study evaluation, in the judgment of the Investigator (e.g. prolapse,\n             myoma, fibroid, hysterectomy).\n\n          7. Subject has a laboratory abnormality Grade \u2265 2, as defined using the Toxicity Grading\n             Scale for Healthy Adult and Adolescent Volunteers Enrolled in Preventative Vaccine\n             Clinical Trials,\n\n          8. Subject has received any live viral vaccine within 3 months or any other non live\n             vaccine within 2 weeks of first study product administration.\n\n          9. Subject has primary or secondary systemic immunosuppression\n\n         10. Subject has a history of severe allergy (requiring hospital care) or history of\n             severe asthma\n\n         11. Subject has a history of malignant cancer, except the following adequately treated\n             cancers: basal cell carcinoma, or dermatological squamous cell carcinoma.\n\n         12. Subject was administered with another investigational drug or vaccine within 30 days\n             prior to the screening visit or is participating in any other study.\n\n         13. Subject has a known hypersensitivity to imiquimod.\n\n         14. Subject has a history of severe reaction to any drug or vaccination.\n\n         15. Subject has a medical condition with clinical and/or biological consequences judged\n             by the Investigator incompatible with vaccination(s).\n\n         16. Subject has positive results for human immunodeficiency virus (HIV), hepatitis B\n             virus (HBV) surface antigen (HBsAg), or hepatitis C virus (HCV).\n\n         17. Subject has a symptomatic vaginal or genital infection\n\n         18. Subject has a history of or currently active genital herpes disease.\n\n         19. Subject is pregnant or is breastfeeding.\n\n         20. Subject has a positive serum human chorionic gonadotrophin (HCG) result at enrolment."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "50 Years", 
            "minimum_age": "25 Years"
        }, 
        "enrollment": {
            "#text": "220", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 4, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01957878", 
            "org_study_id": "PC10VAC02"
        }, 
        "intervention": [
            {
                "arm_group_label": "HPV therapeutic vaccine", 
                "description": "ProCervix consists of two recombinant adenylate cyclase (CyaA) proteins, CyaA-HPV 16E7 (C16-1) and CyaA-HPV 18E7 (C18-1) in a 50/50 ratio (C16C18-2 Ag mixture). ProCervix is adjuvanted by Aldara\u2122, a cream containing 5% of imiquimod", 
                "intervention_name": "ProCervix", 
                "intervention_type": "Biological"
            }, 
            {
                "arm_group_label": "Placebo matching ProCervix", 
                "description": "Placebo matching ProCervix and adjuvanted by Aldara\u2122, a cream containing 5% of imiquimod", 
                "intervention_name": "Placebo", 
                "intervention_type": "Biological"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 26, 2014", 
        "location": [
            {
                "contact": {
                    "email": "gilbert.donders@femicare.net", 
                    "last_name": "Gilbert Donders, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Tienen", 
                        "country": "Belgium", 
                        "state": "Vlaams Brabant"
                    }, 
                    "name": "Regionaal Ziekenhuis Heilig Hart Tienen Hospital"
                }, 
                "investigator": {
                    "last_name": "Gilbert Donders, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "pierre.vandamme@uantwerpen.be", 
                    "last_name": "Pierre Van Damme, MD, PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Antwerp", 
                        "country": "Belgium"
                    }, 
                    "name": "Centre for the Evaluation of Vaccination Vaccine & Infectious Disease Institute (VAXINFECTIO) Faculty of Medicine University of Antwerp Belgium"
                }, 
                "investigator": {
                    "last_name": "Pierre Van Damme, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "jean.sartenaer@skynet.be", 
                    "last_name": "Jean-Guy Sartenaer, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Charleroi", 
                        "country": "Belgium"
                    }, 
                    "name": "Grand H\u00f4pital de Charleroi Site Notre-Dame"
                }, 
                "investigator": {
                    "last_name": "Jean-Guy Sartenaer, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "willy.poppe@uzleuven.be", 
                    "last_name": "Willy Poppe, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Leuven", 
                        "country": "Belgium"
                    }, 
                    "name": "University Hospitals Leuven"
                }, 
                "investigator": {
                    "last_name": "Willy Poppe, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "pekka.nieminen@hus.fi", 
                    "last_name": "Pekka Nieminen, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Helsinki", 
                        "country": "Finland"
                    }, 
                    "name": "Helsinki University Central Hospital"
                }, 
                "investigator": {
                    "last_name": "Pekka Nieminen, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "marjo.tuppurainen@kuh.fi", 
                    "last_name": "Marjo Tuppurainen, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Kuopio", 
                        "country": "Finland"
                    }, 
                    "name": "Kuopio University Hospital"
                }, 
                "investigator": {
                    "last_name": "Marjo Tuppurainen, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "johanna.maenpaa@pshp.fi", 
                    "last_name": "Johanna M\u00e4enp\u00e4\u00e4, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Tampere", 
                        "country": "Finland"
                    }, 
                    "name": "Tampereen yliopistollinen sairaala Hospital"
                }, 
                "investigator": {
                    "last_name": "Johanna M\u00e4enp\u00e4\u00e4, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "gondry.jean@chu-amiens.fr", 
                    "last_name": "Jean Gondry, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Amiens", 
                        "country": "France"
                    }, 
                    "name": "CHU Amiens Hopital Sud"
                }, 
                "investigator": {
                    "last_name": "Jean Gondry, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "didier.riethmuller@univ-fcomte.fr", 
                    "last_name": "Didier Riethmuller, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Besan\u00e7on", 
                        "country": "France"
                    }, 
                    "name": "H\u00f4pital Saint Jacques"
                }, 
                "investigator": {
                    "last_name": "Didier Riethmuller, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "agkaemmerlen@chu-clermontferrand.fr", 
                    "last_name": "Anne-Gaelle Rabishong Kaermmerlen, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Clermont-Ferrand", 
                        "country": "France"
                    }, 
                    "name": "GORH, CHU Estaing"
                }, 
                "investigator": {
                    "last_name": "Anne Gaelle Rabishong Kaermmerlen, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "serge.douvier@chu-dijon.fr", 
                    "last_name": "Serge Douvier, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Dijon", 
                        "country": "France"
                    }, 
                    "name": "CHU Dijon"
                }, 
                "investigator": {
                    "last_name": "Serge Douvier, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "katty.ardaens@chru-lille.fr", 
                    "last_name": "Katty Ardaens, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Lille", 
                        "country": "France"
                    }, 
                    "name": "H\u00f4pital Jeanne de Flandre CHU de Lille"
                }, 
                "investigator": {
                    "last_name": "Katty Ardeans, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "vincent.letouzey@chu-nimes.fr", 
                    "last_name": "Vincent Letouzey, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "N\u00eemes", 
                        "country": "France"
                    }, 
                    "name": "CHU de N\u00eemes - Hopital Universitaire Caremeau"
                }, 
                "investigator": {
                    "last_name": "Vincent Letouzey, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "odile.launay@cch.aphp.fr", 
                    "last_name": "Odile Launay, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France"
                    }, 
                    "name": "Centre d'Investigation Clinique de Vaccinologie Cochin Pasteur (CIC BT505)"
                }, 
                "investigator": {
                    "last_name": "Odile Launay, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "aude.lunel@chu-lyon.fr", 
                    "last_name": "Aude Lunel-Potencier, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Pierre Benite", 
                        "country": "France"
                    }, 
                    "name": "Centre Hospitalier Lyon Sud"
                }, 
                "investigator": {
                    "last_name": "Aude Lunel-Potencier, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "jpbory@chu-reims.fr", 
                    "last_name": "Jean Paul Bory, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Reims", 
                        "country": "France"
                    }, 
                    "name": "CHU de Reims Institut Alix de Champagne"
                }, 
                "investigator": {
                    "last_name": "Jean Paul Bory, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "jean-jacques.baldauf@chru-strasbourg.fr", 
                    "last_name": "Jean-Jacques Baldauf, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Strasbourg", 
                        "country": "France"
                    }, 
                    "name": "H\u00f4pital de Hautepierre"
                }, 
                "investigator": {
                    "last_name": "Jean-Jacques Baldauf, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "guenter.cichon@charite.de", 
                    "last_name": "G\u00fcnter Cichon, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany"
                    }, 
                    "name": "Charit\u00e9 - Universit\u00e4tsmedizin Berlin Hospital"
                }, 
                "investigator": {
                    "last_name": "G\u00fcnter Cichon, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "grit.mehlhorn@uk-erlangen.de", 
                    "last_name": "Grit Mehlhorn, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Erlangen", 
                        "country": "Germany"
                    }, 
                    "name": "Universit\u00e4tsklinikum Erlangen Hospital"
                }, 
                "investigator": {
                    "last_name": "Grit Mehlhorn, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "f.piczlewicz@contilia.de", 
                    "last_name": "Frank Piczlewicz, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Essen", 
                        "country": "Germany"
                    }, 
                    "name": "Elisabeth Krankenhaus Essen GmbH - Clinic/Outpatient Facility"
                }, 
                "investigator": {
                    "last_name": "Frank Piczlewicz, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "cornelia.scheungraber@med.uni-jena.de", 
                    "last_name": "Cornelia Scheungraber, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Jena", 
                        "country": "Germany"
                    }, 
                    "name": "Klinikum der Friedrich Schiller Universit\u00e4t Jena Hospital"
                }, 
                "investigator": {
                    "last_name": "Cornelia Scheungraber, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "christian.dannecker@med.uni-muenchen.de", 
                    "last_name": "Christian Dannecker, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "M\u00fcnchen", 
                        "country": "Germany"
                    }, 
                    "name": "LMU Klinikum der Universit\u00e4t- Hospital"
                }, 
                "investigator": {
                    "last_name": "Christian Dannecker, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "k.u.petry@klinikum.wolfsburg.de", 
                    "last_name": "Karl Ulrich Petry, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Wolfsburg", 
                        "country": "Germany"
                    }, 
                    "name": "Klinikum Wolfsburg Hospital"
                }, 
                "investigator": {
                    "last_name": "Karl Ulrich Petry, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "g.kenter@vumc.nl", 
                    "last_name": "Gemma Kenter, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Amsterdam", 
                        "country": "Netherlands"
                    }, 
                    "name": "Center Gynaecological Oncology Amsterdam AMC, NKI-AVL, VUmc"
                }, 
                "investigator": {
                    "last_name": "Gemma Kenter, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "j.schagen@antonius.net", 
                    "last_name": "Jules Schagen Van Leeuwen, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Nieuwegein", 
                        "country": "Netherlands"
                    }, 
                    "name": "St. Antonius Ziekenhuis Hospital"
                }, 
                "investigator": {
                    "last_name": "Jules Schagen Van Leeuwen, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "atorne@clinic.ub.es", 
                    "last_name": "Aurell Torne-Blade, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital Clinic Dept of Obstetrics and Gynecology C/ Villarroel Unidad de Ginecolog\u00eda Oncol\u00f3gica, Instituto Cl\u00ednico de Ginecolog\u00eda y Obstetricia y Neonatolog\u00eda (ICGON), Hospital Cl\u00ednic, Instituto de Investigaciones Biom\u00e9di"
                }, 
                "investigator": {
                    "last_name": "Aurell Torne-Blade, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "gmancebo@parcdesaiutmar.cat", 
                    "last_name": "Gemma Mancebo, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital del Mar"
                }, 
                "investigator": {
                    "last_name": "Gemma Mancebo, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "criscent@telefonica.net", 
                    "last_name": "Cristina Centeno Mediavilla, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital Universitari Vall D Hebron"
                }, 
                "investigator": {
                    "last_name": "Cristina Centeno Mediavilla, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "xcastellsague@iconcologia.net", 
                    "last_name": "Xavier Castellsagu\u00e9, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain"
                    }, 
                    "name": "Institut Catala d'Oncologia L'Hopitalet de Llobregat"
                }, 
                "investigator": {
                    "last_name": "X Castellsagu\u00e9, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "fvazquezf@telefonica.net", 
                    "last_name": "Francisco Vazquez Fernandez"
                }, 
                "facility": {
                    "address": {
                        "city": "Lugo", 
                        "country": "Spain"
                    }, 
                    "name": "Clinica Ginecologica Ceoga, Clinic/Outpatient Facility"
                }, 
                "investigator": {
                    "last_name": "Francisco Vazquez Fernandez, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "mserranovelasco@gmail.com", 
                    "last_name": "Maria Serrano Velasco, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital La Paz de Madrid"
                }, 
                "investigator": {
                    "last_name": "Maria Serrano Velasco, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "jvidarta@sego.es", 
                    "last_name": "Jose Antonio Vidart Aragon, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital Cl\u00ednico San Carlos"
                }, 
                "investigator": {
                    "last_name": "Jose Antonio Vidart Aragon", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "jjimenezl@salud.madrid.org", 
                    "last_name": "Jesus Jimenez L\u00f3pez, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital Universitario \"12 de Octubre\""
                }, 
                "investigator": {
                    "last_name": "Jesus Jimenez L\u00f3pez, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "evillegasm@sego.es", 
                    "last_name": "Emilia del Carmen Villegas Mu\u00f1oz, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Malaga", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital Regional Universitario Carlos Haya - Hospital Materno Infantil"
                }, 
                "investigator": {
                    "last_name": "Emilia del Carmen Villegas Mu\u00f1oz, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "joseantonio@vargaslazcano.es", 
                    "last_name": "Jos\u00e9 Antonio Vargas Lazcano, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Sevilla", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital Sagrado Coraz\u00f3n de Sevilla"
                }, 
                "investigator": {
                    "last_name": "Jos\u00e9 Antonio Vargas Lazcano, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "heather.currie@nhs.net", 
                    "last_name": "Heather Currie, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Dumfries", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Dumfries and Galloway Royal Infirmary Hospital"
                }, 
                "investigator": {
                    "last_name": "Heather Currie, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "mark@marklawton.com", 
                    "last_name": "Mark Lawton, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Liverpool", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Liverpool - GUM - Liverpool Centre for Sexual Health"
                }, 
                "investigator": {
                    "last_name": "Mark Lawton, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "Deirdre.Lyons@imperial.nhs.uk", 
                    "last_name": "Deidre Lyons, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "United Kingdom"
                    }, 
                    "name": "St Mary's Hospital"
                }, 
                "investigator": {
                    "last_name": "Deidre Lyons, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "henry.c.kitchener@manchester.ac.uk", 
                    "last_name": "Henry Kitchener, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Manchester", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Academic O&G University of Manchester Research - St Mary's Hospital"
                }, 
                "investigator": {
                    "last_name": "Henry Kitchener, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "charles.lacey@hyms.ac.uk", 
                    "last_name": "Charles Lacey, MD, PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "York", 
                        "country": "United Kingdom"
                    }, 
                    "name": "The Centre for Immunology and Infection Hull York Medical School University of York"
                }, 
                "investigator": {
                    "last_name": "Charles Lacey, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "Belgium", 
                "Finland", 
                "France", 
                "Germany", 
                "Netherlands", 
                "Spain", 
                "United Kingdom"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "A Double-blind, Randomised, Placebo-controlled, Phase II Study to Evaluate ProCervix Efficacy to Clear HPV 16 and HPV 18 Infection in Women With Normal Cytology or ASCUS/LSIL", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Belgium: Federal Agency for Medicines and Health Products, FAMHP", 
                "Finland: Finnish National Agency for Medicines", 
                "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
                "Germany: Paul-Ehrlich-Institut", 
                "Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)", 
                "Spain: Spanish Agency of Medicines", 
                "United Kingdom: Medicines and Healthcare Products Regulatory Agency"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Clearance  of HPV 16 and HPV 18 infection at Month 12 using a type specific, sensitive and quantitative HPV PCR assay.", 
            "safety_issue": "No", 
            "time_frame": "month 12"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01957878"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Clearance  of HPV 16 and HPV 18 infection.", 
            "safety_issue": "No", 
            "time_frame": "Month 6, 15, 18, 24"
        }, 
        "source": "Genticel", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Genticel", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}